Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Net Income towards Common Stockholders (2018 - 2025)

Historic Net Income towards Common Stockholders for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$20.0 million.

  • Precision Biosciences' Net Income towards Common Stockholders fell 118.37% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.0 million, marking a year-over-year decrease of 2935479.45%. This contributed to the annual value of -$18.8 million for FY2023, which is 5147.7% up from last year.
  • Latest data reveals that Precision Biosciences reported Net Income towards Common Stockholders of -$20.0 million as of Q3 2025, which was down 118.37% from -$21.1 million recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Net Income towards Common Stockholders registered a high of $25.4 million during Q2 2024, and its lowest value of -$30.7 million during Q4 2021.
  • Its 5-year average for Net Income towards Common Stockholders is -$11.3 million, with a median of -$11.6 million in 2021.
  • Data for Precision Biosciences' Net Income towards Common Stockholders shows a peak YoY increase of 38707.38% (in 2024) and a maximum YoY decrease of 73166.37% (in 2024) over the last 5 years.
  • Precision Biosciences' Net Income towards Common Stockholders (Quarter) stood at -$30.7 million in 2021, then soared by 70.5% to -$9.1 million in 2022, then skyrocketed by 68.49% to -$2.9 million in 2023, then crashed by 731.66% to -$23.7 million in 2024, then grew by 15.76% to -$20.0 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$20.0 million for Q3 2025, versus -$21.1 million for Q2 2025 and -$21.1 million for Q1 2025.